Thor Medical ASA
OSE:TRMED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Thor Medical ASA (TRMED) under the Base Case is NOK per share. Compared with the current market price of 4.17 NOK, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Thor Medical ASA Does
Thor Medical ASA is a Norwegian life-sciences company that develops and supplies radioisotopes for cancer treatment. Its main focus is alpha-emitting materials used in targeted radiopharmaceuticals, which are medicines designed to deliver radiation directly to tumor cells while limiting damage to healthy tissue. The company works in the upstream part of this value chain, turning raw thorium-based material into medical-grade isotope products.
- Headquarters
- Norway NO
- Employees
- 18
- IPO date
- Jul 7, 2014
Revenue & Expenses Breakdown
Thor Medical ASA
Earnings Waterfall
Thor Medical ASA
What is the Intrinsic Value of one TRMED stock?
The intrinsic value for Thor Medical ASA (TRMED) under the Base Case is NOK.
Is TRMED stock undervalued or overvalued?
Compared with the current market price of 4.17 NOK, the stock appears .